Table 2 Association between single SNPs and MM risk.

From: Genetically determined telomere length and multiple myeloma risk and outcome

SNP

Gene

Allele

MAFa

EAa

Allelic modelb

Codominant modelc

M/m

HR1

95% CI1

Pvalue

HRHet

95% CI

Pvalue

HRHom

95% CI

Pvalue

rs11125529

ACYP2

C/A

0.11

A

0.99

0.86–1.16

0.994

1.10

0.92–1.31

0.299

0.63

0.37–1.07

0.093

rs6772228

PXK

T/A

0.04

T

0.81

0.62–1.07

0.121

0.75

0.50–0.99

0.048

1.91

0.43–8.32

0.389

rs10936599

TERC

C/T

0.24

C

0.79

0.70–0.90

1.72 × 10−4

0.84

0.72–0.98

0.027

0.55

0.39–0.76

2.87 × 10−4

rs7675998

NAF1

G/A

0.24

G

0.94

0.83–1.06

0.321

0.84

0.73–0.98

0.029

1.15

0.82–1.60

0.402

rs2736100

TERT

A/C

0.5

C

1.07

0.96–1.18

0.223

1.07

0.89–1.28

0.479

1.14

0.92–1.39

0.223

rs9420907

OBFC1

A/C

0.13

C

1.17

1.03–1.35

0.020

1.32

1.12–1.55

7.78 × 10−4

0.88

0.57–1.35

0.556

rs3027234

CTC1

C/T

0.22

C

0.89

0.79–1.00

0.054

0.97

0.83–1.13

0.669

0.65

0.47–0.90

0.009

rs8105767

ZNF208

A/G

0.28

G

1.14

1.02–1.27

0.022

1.05

0.90–1.21

0.559

1.46

1.12–1.90

0.005

rs412658

ZNF676

C/T

0.35

T

1.01

0.91–1.12

0.866

1.02

0.88–1.18

0.826

1.01

0.81–1.27

0.920

rs6028466

DHX35

G/A

0.07

A

1.23

1.08–1.50

0.042

1.25

1.00–1.55

0.048

1.33

0.55–3.15

0.505

rs755017

ZBTB46

A/G

0.12

G

1.10

0.93–1.29

0.235

1.05

0.88–1.25

0.609

1.61

0.88–2.93

0.120

  1. aMAF minor allele frequency, EA effect allele, allele associated with longer telomere length, OR odds ratio, 95% CI 95% coefficient interval.
  2. bAllelic model: M vs. m, common allele vs. rare allele.
  3. cCodominant model: Mm vs. MM, heterozygous carriers vs. common homozygous, mm vs. MM, rare homozygous vs. common homozygous.